CD19 and acute lymphoblastic leukemia: tested allogeneic CD19 CAR-T cells in two phase I studies, treating pediatric (n = 7, NCT02808442 PALL study) or adult patients (n=14, NCT02746952 CALM study) with r/r B-ALL.